https://pmc.ncbi.nlm.nih.gov/articles/PMC8250295/

As the world continues to explore ways to protect against COVID-19, fascinating research is emerging on the potential antiviral effects of ketone bodies — the compounds produced by our bodies during ketosis. Could achieving a state of ketosis actually neutralize the virus at a structural level? Let’s dive into the science.

---

What Are Ketone Bodies?

Ketone bodies are molecules produced in the liver from fatty acids when carbohydrate intake is low — such as during fasting, starvation, or low-carbohydrate ketogenic diets.
The three primary ketone bodies found in human blood are:

• Beta-hydroxybutyrate (BHB) — C₄H₇O₃⁻
• Acetoacetate (AcAc) — C₄H₅O₃⁻
• Acetone — C₃H₆O (least abundant)

Ketone bodies serve as an alternative energy source when glucose is scarce. However, their benefits may extend beyond metabolism — reaching into antiviral defense mechanisms.

---

How Ketone Bodies May Affect the COVID-19 Spike Protein

The spike protein of the SARS-CoV-2 virus is critical for infecting human cells.
It binds to ACE2 receptors, allowing the virus to enter and hijack the host’s cellular machinery.

Here’s where ketone bodies, particularly acetoacetate, come into the picture:

• Acetoacetate has been shown to react with lysine residues on proteins, forming Schiff bases — chemical bonds that can alter protein structure.
• Studies have observed that acetoacetate can reduce α-helix content in proteins, a key structural feature needed for stability and function.
• Interestingly, these effects are similar to formaldehyde and glutaraldehyde, two chemical fixatives known to denature proteins.

Because ketone bodies are small molecules (only 3–4 carbons long), they can penetrate and interact with proteins much like these fixatives — but in a natural and biologically tolerated way.

Hypothesis:

If ketone bodies, particularly acetoacetate, interact with the spike proteins of SARS-CoV-2, they may:

• Bend, break, or destabilize the spike structures.
• Reduce the virus’s ability to bind to human cells.
• Lower infectivity both inside the body and in bodily secretions (reducing transmission to others).

---

Ketosis: A Potential Therapeutic and Preventive Strategy?

If confirmed by experimental studies, inducing ketosis could offer both therapeutic and preventive benefits:

• In infected patients:
  Higher levels of ketone bodies could inhibit the spread of the virus from cell to cell, slow down disease progression, and reduce infectivity to others.
• In healthy individuals:
  Maintaining a physiological level of ketone bodies might decrease the severity of infection or even enhance resistance to initial infection.

This approach would complement, rather than replace, traditional medical treatments and preventive measures like vaccination.

---

The Need for Experimental Validation

While the hypothesis is promising, it is important to note that direct experimental evidence confirming ketone bodies’ ability to inactivate SARS-CoV-2 spikes is still lacking.
Controlled studies are needed to establish:

• How effectively ketone bodies modify viral spike proteins in biological systems.
• Whether such modifications meaningfully reduce infectivity.
• The optimal level of ketosis needed for antiviral effects without adverse consequences.

Until such studies are completed, the idea remains an exciting and plausible theory — but not yet a proven clinical strategy.

---

Final Thoughts

The idea that ketosis could help deactivate COVID-19’s spike protein opens up fascinating possibilities for both treatment and prevention.
By harnessing the natural biochemical pathways of the body — through diet, fasting, or ketogenic interventions — we might have a powerful, low-cost way to enhance viral resistance.

However, until scientific validation is achieved, ketosis should be viewed as a complementary lifestyle approach rather than a replacement for medical advice or vaccination.

The interplay between nutrition, metabolism, and immunity continues to amaze — and ketosis may soon have an even bigger role in our battle against infectious diseases.

Stay tuned as research in this area continues to unfold!